Dupilumab improves symptoms, quality of life, and productivity in uncontrolled persistent asthma.
- DOI
- 10.1016/j.anai.2018.08.005
- Published
- 2019 Jan
- Container
- Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.anai.2018.08.005,
title = {Dupilumab improves symptoms, quality of life, and productivity in uncontrolled persistent asthma.},
author = {Corren J and Castro M and Chanez P and Fabbri L and Joish VN and Amin N and Graham NMH and Mastey V and Abbé A and Taniou C and Mahajan P and Teper A and Pirozzi G and Eckert L},
year = {2019},
journal = {Annals of allergy, asthma \& immunology : official publication of the American College of Allergy, Asthma, \& Immunology},
doi = {10.1016/j.anai.2018.08.005},
url = {https://doi.org/10.1016/j.anai.2018.08.005}
}RIS
TY - JOUR TI - Dupilumab improves symptoms, quality of life, and productivity in uncontrolled persistent asthma. AU - Corren J AU - Castro M AU - Chanez P AU - Fabbri L AU - Joish VN AU - Amin N AU - Graham NMH AU - Mastey V AU - Abbé A AU - Taniou C AU - Mahajan P AU - Teper A AU - Pirozzi G AU - Eckert L PY - 2019 JO - Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology DO - 10.1016/j.anai.2018.08.005 UR - https://doi.org/10.1016/j.anai.2018.08.005 ER -
APA
J, C., M, C., P, C., L, F., VN, J., N, A., NMH, G., V, M., A, A., C, T., P, M., A, T., G, P., & L, E. (2019). Dupilumab improves symptoms, quality of life, and productivity in uncontrolled persistent asthma.. Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology. https://doi.org/10.1016/j.anai.2018.08.005
Source records
- pubmed · retrieved 2026-09-25T21:42:13.779Z